Lastly, we analyzed single-cell RNA-seq data from 18 ACC metastatic tumors (Aber et al. manuscript in submission) and observed a significantly higher ADS among cells with high DLK1 expression compared to cells with low or no DLK1 expression (Fig. 4K) supporting our experimental results. The gene discussed is DLK1; the disease is adrenal cortex carcinoma.